BECN1 and non-Hodgkin lymphoma: In squamous cell carcinomas of the uterine cervix the overexpression of Beclin-1 has been reported to inhibit metastatic progression in vitro (63), and in non-Hodgkin lymphomas (NHL), the increased expression of Beclin-1 has been found related to an increase in LC3-positive autophagic vacuoles and a better outcome of patients after chemotherapy (64).